Page last updated: 2024-11-08

sr 90107

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

fondaparinux sodium : An organic sodium salt, being the decasodium salt of fondaparinux. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID636380
CHEMBL ID1200644
MeSH IDM0324779

Synonyms (54)

Synonym
quixidar
sr-90107
fondaparinux sodium
org-31540
sr-90107a
gsk-576428
fondaparin sodium
org 31540
D01844
arixtra (tn)
fondaparinux sodium (jan/usp/inn)
114870-03-0
xantidar
alpha-d-glucopyranoside, methyl o-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranuronosyl(1-4)-o-2-deoxy-3,6-di-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-2-o-sulfo-alpha-l-idopyranuronosyl-(1-4)-2-deoxy-2-(sul
sr 90107a
fondaparinux sodium [usan]
methly o-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-beta-d-glucopyranuronosyl-(1-4)-o-2-deoxy-3,6-di-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-4)-o-2-o-sulfo-alpha-l-idopyranuronosyl-(1-4)-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha
ic 85158
fondaparinux sodium identification
fondaparinux sodium for assay
CHEMBL1200644
ic-851589
AKOS005146286
decasodium 6-[6-[2-carboxylato-4-hydroxy-6-[4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-5-sulfonatooxy-tetrahydropyran-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)tetrahydropyran-3-yl]oxy-3-[4
A803253
fondaparinux sodium [usan:inn:ban]
x0q6n9usoz ,
unii-x0q6n9usoz
fondaparinux sodium [usp-rs]
fondaparinux sodium [usp monograph]
fondaparinux sodium [who-dd]
fondaparinux sodium [mart.]
fondaparinux sodium [orange book]
fondaparinux sodium [jan]
fondaparinux sodium [mi]
fondaparinux sodium [inn]
fondaparinux sodium [ema epar]
Q421218
natural heparin pentasaccharide sodium
alpha-d-glucopyranoside, methyl o-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-->4)-o-beta-d-glucopyranuronosyl-(1-->4)-o-2-deoxy-3,6-di-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1-->4)-o-2-o-sulfo-alpha-l-idopyranuronosyl-(1-->4)-2-deo
CCG-270693
C71476
DTXSID501027612
AS-80003
bdbm50604260
decasodium methyl o-(2-deoxy-6-o-sulfo-2-sulfoamino-alpha-d-glucopyranosyl)-(1->4)-o-(beta-d-glucopyranosyluronic acid)-(1->4)-o-(2-deoxy-3,6-di-o-sulfo-2-sulfoamino-alpha-d-glucopyranosyl)-(1->4)-o-(2-o-sulfo-alpha-l-idopyranosyluronic acid)-(1->4)-2
fondaparinuxum natricum
fondaparinux sodico
fondaparinux sodium (usp-rs)
fondaparinux sodique
fondaparinux sodium (usp monograph)
b01ax05
methyl o-2-deoxy-6-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1->4)-o-beta-d-glucopyra-nuronosyl-(1->4)-o-2-deoxy-3,6-di-o-sulfo-2-(sulfoamino)-alpha-d-glucopyranosyl-(1->4)-o-2-o-sulfo-alpha-l-idopyranuronosyl-(1->4)-2-deoxy-6-o-sulfo-2-(sulfoamino)-
fondaparinux sodium (mart.)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Coagulation factor XHomo sapiens (human)IC50 (µMol)9.59760.00030.593710.0000AID1904955; AID1904956
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
proteolysisCoagulation factor XHomo sapiens (human)
blood coagulationCoagulation factor XHomo sapiens (human)
positive regulation of cell migrationCoagulation factor XHomo sapiens (human)
positive regulation of TOR signalingCoagulation factor XHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (4)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityCoagulation factor XHomo sapiens (human)
calcium ion bindingCoagulation factor XHomo sapiens (human)
protein bindingCoagulation factor XHomo sapiens (human)
phospholipid bindingCoagulation factor XHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (6)

Processvia Protein(s)Taxonomy
extracellular regionCoagulation factor XHomo sapiens (human)
endoplasmic reticulum lumenCoagulation factor XHomo sapiens (human)
Golgi lumenCoagulation factor XHomo sapiens (human)
plasma membraneCoagulation factor XHomo sapiens (human)
external side of plasma membraneCoagulation factor XHomo sapiens (human)
extracellular spaceCoagulation factor XHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (41)

Assay IDTitleYearJournalArticle
AID625280Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625292Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904950AUC (0 to infinity) in Sprague-Dawley rat at 100 nmol/kg, sc2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904954Anticoagulant activity in human plasma assessed as prolongation of thrombin time by measuring concentration required to double TT incubated for 3 mins by coagulometer analysis2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID625289Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904966Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 300 nmol/kg, sc measured after 2 hrs relative to control2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID625287Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904951AUC (0 to 32 hrs) in Sprague-Dawley rat at 100 nmol/kg, sc measured after 32 hrs2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904952Anticoagulant activity in human plasma assessed as prolongation of activated partial thromboplastin time by measuring concentration required to double APTT incubated for 3 mins by coagulometer analysis2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID690051Binding affinity to human plasma antithrombin assessed as decrease in intrinsic tryptophan fluorescence by fluorescence spectroscopy2011Journal of medicinal chemistry, Sep-08, Volume: 54, Issue:17
Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.
AID1385754Binding affinity to recombinant HSV1 glycoprotein D (21 to 339 residues) assessed as change in intrinsic tryptophan fluorescence by spectrofluorimetric method2018ACS medicinal chemistry letters, Aug-09, Volume: 9, Issue:8
Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan Mimetics.
AID625282Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625290Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID699259Binding affinity to purified human antithrombin at 64 uM by isothermal titration calorimetry2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity.
AID625284Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904958Tmax in Sprague-Dawley rat at 100 nmol/kg, sc2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904961Clearance in Sprague-Dawley rat at 100 nmol/kg, sc2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904965Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 100 nmol/kg, sc measured after 2 hrs relative to control2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID690053Activation of human plasma antithrombin assessed as acceleration of antithrombin-mediated human F10a inhibition at pH 6.0, 25 mM NaCl and 25 degC using spectrophotometry based discontinuous slow kinetic assay relative to untreated control2011Journal of medicinal chemistry, Sep-08, Volume: 54, Issue:17
Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.
AID1904957Anticoagulant activity in human platelet poor plasma assessed as inhibition of thrombin generation incubated for 3 mins by calibrated automated thrombogram analysis2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904962Volume of distribution in Sprague-Dawley rat at 100 nmol/kg, sc2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID625288Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625279Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID625286Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904953Anticoagulant activity in human plasma assessed as prolongation of prothrombin time by measuring concentration required to double PT incubated for 3 mins by coagulometer analysis2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID701167Binding affinity to human antithrombin by spectrofluorometric analysis2012Journal of medicinal chemistry, Aug-09, Volume: 55, Issue:15
Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition.
AID625291Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904955Inhibition of coagulation factor Xa (unknown origin) using chromogenic substrate incubated for 7 min in presence of antithrombin by absorbance based assay2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904949Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 100 nmol/kg, sc measured after 1 hr2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904959Cmax in Sprague-Dawley rat at 100 nmol/kg, sc2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID625283Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1904960Half life in Sprague-Dawley rat at 100 nmol/kg, sc2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID699258Binding affinity to purified human antithrombin at 64 uM in presence of 37 uM d-myo-inositol 3,4,5,6-tetrakisphosphate by isothermal titration calorimetry2012Journal of medicinal chemistry, Jul-26, Volume: 55, Issue:14
In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity.
AID1904956Inhibition of heparin binding to factor 10a using chromogenic substrate incubated for 7 min by absorbance based assay2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1853706Inhibition of coagulation factor Xa (unknown origin) using FXa specific chromogenic substrate at 0.001 to 10 ug/ml preincubated for 2 mins in presence of antithrombin III followed by factor Xa addition for 2 mins and chromogenic substrate and measured aft2021RSC medicinal chemistry, Dec-15, Volume: 12, Issue:12
Synthesis of low-molecular weight fucoidan derivatives and their binding abilities to SARS-CoV-2 spike proteins.
AID625281Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
AID1474167Liver toxicity in human assessed as induction of drug-induced liver injury by measuring verified drug-induced liver injury concern status2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID1904964Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 30 nmol/kg, sc measured after 2 hrs relative to control2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1904963Antithrombotic activity in Sprague-Dawley rat model of blood stasis-induced venous thrombosis assessed as inhibition of thrombosis rate at 100 nmol/kg, sc measured after 1 hr relative to control2022European journal of medicinal chemistry, Apr-15, Volume: 234Chemical synthesis and pharmacological properties of heparin pentasaccharide analogues.
AID1474166Liver toxicity in human assessed as induction of drug-induced liver injury by measuring severity class index2016Drug discovery today, Apr, Volume: 21, Issue:4
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
AID625285Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis2011PLoS computational biology, Dec, Volume: 7, Issue:12
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.42 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]